PS Ratio
N/A
3 min ago
Summary:
Checkpoint Therapeutics price to sales ratio is not available.CKPT PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CKPT PS Ratio Performance
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | - | -0.9% | -0.9% | - |
| 1 m1 month | - | -22.4% | -22.4% | - |
| 3 m3 months | - | +50.0% | +60.0% | - |
| 6 m6 months | - | +59.1% | +83.5% | - |
| ytdytd | - | +50.0% | +164.0% | - |
| 1 y1 year | - | +50.0% | +211.3% | - |
| 5 y5 years | - | -79.5% | +86.5% | - |
CKPT PS Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | ||||
| 3 m | 3 months | 1298.53 | 1298.53 | ||
| 6 m | 6 months | 1552.58 | 1112.56 | ||
| 1 y | 1 year | 1552.58 | 310.93 | ||
| 3 y | 3 years | 1552.58 | 159.65 | ||
| 5 y | 5 years | 1552.58 | 18.31 | ||
| alltime | all time | 1552.58 | 10.54 |
Checkpoint Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2023 | 614.09(+131.8%) |
| 2022 | 264.96(-73.0%) |
| 2021 | 981.44(+470.3%) |
| 2020 | 172.09(+216.5%) |
| Date | Value |
|---|---|
| 2019 | 54.38(+207.4%) |
| 2018 | 17.69(-69.2%) |
| 2017 | 57.38(-24.5%) |
| 2016 | 76.04 |
FAQ
- What is the all time high PS ratio for Checkpoint Therapeutics?
What is the all time high PS ratio for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high price to sales ratio is 1552.58